Lollicaine Mint Gel, Dentifrice
NDC Package 60640-9200-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Lollicaine Mint (benzocaine) gel is do not exceed recommended dosage.Adults and children 2 years of age and older: apply to affected area up to 4 times daily or as directed by dentist or doctor.Children under 12 years of age: should be supervised in the use of the product.Children under 2 years of age: do not use. This formulation utilizes a gel, dentifrice delivery system. Marketed by Centrix, Inc., this product is identified by NDC 60640-9200 and is authorized under FDA application M022.

Identification & Billing

NDC Package Code
60640-9200-1
Package Description
120 DOSE PACK in 1 CARTON / .4 g in 1 DOSE PACK
Product Code
60640-9200
11-Digit Billing Format
60640920001
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Lollicaine Mint
Non-Proprietary Name
Benzocaine
Substance Name
Benzocaine
Dosage Form
Gel, Dentifrice - A combination of a dentifrice (formulation intended to clean and/or polish the teeth, and which may contain certain additional agents), and a gel. It is used with a toothbrush for the purpose of cleaning and polishing the teeth.
Administration Route
Dental - Administration to a tooth or teeth.
Active Ingredient(s)
BENZOCAINE 200 mg/g
Pharmacologic Class
Usage Information
Do not exceed recommended dosage.Adults and children 2 years of age and older: apply to affected area up to 4 times daily or as directed by dentist or doctor.Children under 12 years of age: should be supervised in the use of the product.Children under 2 years of age: do not use

Regulatory & Marketing

Labeler Name
Centrix, Inc.
Product Type
Human Otc Drug
FDA Application #
M022
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
01-14-2019
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 60640-9200-1 identifies a specific commercial package of 120 dose pack in 1 carton / .4 g in 1 dose pack of Lollicaine Mint, a human over the counter drug labeled by Centrix, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This gel, dentifrice is formulated for dental use and contains benzocaine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Centrix, Inc. on January 14, 2019. The current certification is valid through December 31, 2026.

How is this Centrix, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 60640920001. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
60640-9200-1
11-Digit CMS (5-4-2)
60640-9200-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.